LUKAS SCHEIBLER - 06 Sep 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Research Officer
Signature
/s/ David Watson, attorney-in-fact for Lukas Scheibler
Issuer symbol
APLS
Transactions as of
06 Sep 2023
Net transactions value
-$75,526
Form type
4
Filing time
07 Sep 2023, 16:08:01 UTC
Previous filing
22 Feb 2023
Next filing
05 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $75,526 -1,756 -2.5% $43.01 68,299 06 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This includes 412 shares from 04/30/2023 ESPP purchase.